BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Feng W, Hua K, Gudlaugsson E, Yu Y, Zhou X, Baak JPA. Prognostic indicators in WHO 2003 low-grade endometrial stromal sarcoma: Prognostic indicators in WHO 2003 low-grade endometrial stromal sarcoma. Histopathology 2013;62:675-87. [DOI: 10.1111/j.1365-2559.2011.04115.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Yu HY, Jin YL. Metastatic low-grade endometrial stromal sarcoma with variable morphologies in the ovaries and mesentery: A case report. World J Clin Cases 2022; 10(23): 8384-8391 [DOI: 10.12998/wjcc.v10.i23.8384] [Reference Citation Analysis]
2 Borella F, Bertero L, Cassoni P, Piovano E, Gallio N, Preti M, Cosma S, Ferraioli D, Pace L, Mariani L, Biglia N, Benedetto C. Low-Grade Uterine Endometrial Stromal Sarcoma: Prognostic Analysis of Clinico-Pathological Characteristics, Surgical Management, and Adjuvant Treatments. Experience From Two Referral Centers. Front Oncol 2022;12:883344. [DOI: 10.3389/fonc.2022.883344] [Reference Citation Analysis]
3 Meng Y, Quan Q, Zhang F, Liu Y, Ren S, Mu X. Prognostic Value of Ki-67 Index in Patients With Endometrial Stromal Sarcoma. Front Med 2022;8:823505. [DOI: 10.3389/fmed.2021.823505] [Reference Citation Analysis]
4 Dai Q, Xu B, Wu H, You Y, Wu M, Li L. The prognosis of recurrent low-grade endometrial stromal sarcoma: a retrospective cohort study. Orphanet J Rare Dis 2021;16:160. [PMID: 33827628 DOI: 10.1186/s13023-021-01802-8] [Reference Citation Analysis]
5 Horn LC, Höhn AK, Denschlag D, Follmann M, Schmidt D. [Interdisciplinary S2k guidelines on the diagnosis and treatment of uterine sarcomas-recommendations for surgical pathology]. Pathologe 2020;41:621-33. [PMID: 32940744 DOI: 10.1007/s00292-020-00826-4] [Reference Citation Analysis]
6 Ayhan A, Toptas T, Oz M, Vardar MA, Kayikcioglu F, Ozgul N, Gokcu M, Simsek T, Tunc M, Meydanli MM. Low-grade endometrial stromal sarcoma: A Turkish uterine sarcoma group study analyzing prognostic factors and disease outcomes. Gynecol Oncol 2021;160:674-80. [PMID: 33375988 DOI: 10.1016/j.ygyno.2020.12.017] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Mindiola-Romero AE, Liu X, Dillon JL, Talarico M, Smith G, Zhang L, Linos K. Metastatic low-grade endometrial stromal sarcoma after 24 years: A case report and review of recent molecular genetics. Diagn Cytopathol 2021;49:E99-E105. [PMID: 32910526 DOI: 10.1002/dc.24601] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Comert GK, Turkmen O, Kar I, Yucel O, Kilic C, Boran N, Basaran D, Karalok A, Turan T. Hormone therapy following surgery in low-grade endometrial stromal sarcoma: Is it related to a decrease in recurrence rate? J Chin Med Assoc 2019;82:385-9. [PMID: 31058712 DOI: 10.1097/JCMA.0000000000000039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
9 Meurer M, Floquet A, Ray-Coquard I, Bertucci F, Auriche M, Cordoba A, Piperno-Neumann S, Salas S, Delannes M, Chevalier T, Italiano A, Blay JY, Mancini J, Pautier P, Duffaud F. Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: a retrospective series of the French Sarcoma Group. Int J Gynecol Cancer. 2019;29:691-698. [PMID: 30772825 DOI: 10.1136/ijgc-2018-000064] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
10 Díaz-montes TP, El-sharkawy F, Lynam S, Harper A, Sittig M, Macdonald R, Gushchin V, Sardi A. Efficacy of Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in the Treatment of Recurrent Uterine Sarcoma: . International Journal of Gynecological Cancer 2018;28:1130-7. [DOI: 10.1097/igc.0000000000001289] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
11 Nasioudis D, Chapman-Davis E, Frey M, Holcomb K. Safety of ovarian preservation in premenopausal women with stage I uterine sarcoma. J Gynecol Oncol 2017;28:e46. [PMID: 28541635 DOI: 10.3802/jgo.2017.28.e46] [Cited by in Crossref: 15] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
12 Zhou J, Zheng H, Wu SG, He ZY, Li FY, Su GQ, Sun JY. Influence of different treatment modalities on survival of patients with low-grade endometrial stromal sarcoma: A retrospective cohort study. Int J Surg. 2015;23:147-151. [PMID: 26449652 DOI: 10.1016/j.ijsu.2015.09.072] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
13 Morimoto A, Tsubamoto H, Inoue K, Ikeda Y, Hirota S. Fatal case of multiple recurrences of endometrial stromal sarcoma after fertility-sparing management: Fatal endometrial stromal sarcoma. J Obstet Gynaecol Res 2015;41:162-6. [DOI: 10.1111/jog.12506] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
14 Gremel G, Liew M, Hamzei F, Hardell E, Selling J, Ghaderi M, Stemme S, Pontén F, Carlson JW. A prognosis based classification of undifferentiated uterine sarcomas: identification of mitotic index, hormone receptors and YWHAE-FAM22 translocation status as predictors of survival. Int J Cancer 2015;136:1608-18. [PMID: 25130488 DOI: 10.1002/ijc.29141] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
15 Hrzenjak A, Dieber-Rotheneder M, Moinfar F, Petru E, Zatloukal K. Molecular mechanisms of endometrial stromal sarcoma and undifferentiated endometrial sarcoma as premises for new therapeutic strategies. Cancer Lett 2014;354:21-7. [PMID: 25128649 DOI: 10.1016/j.canlet.2014.08.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
16 Yoon A, Park J, Park J, Lee Y, Kim T, Choi CH, Bae D, Kim B, Lee J, Nam J. Prognostic factors and outcomes in endometrial stromal sarcoma with the 2009 FIGO staging system: A multicenter review of 114 cases. Gynecologic Oncology 2014;132:70-5. [DOI: 10.1016/j.ygyno.2013.10.029] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
17 Feng W, Malpica A, Skaland I, Gudlaugsson E, Robboy SJ, Dalen I, Hua K, Zhou X, Baak JP. Can proliferation biomarkers reliably predict recurrence in World Health Organization 2003 defined endometrial stromal sarcoma, low grade? PLoS One 2013;8:e75899. [PMID: 24146786 DOI: 10.1371/journal.pone.0075899] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]